omniture
GENCURIX

Latest News

Gencurix's Study Explores the Difference between GenesWell BCT and Oncotype DX

SEOUL, South Korea, Aug. 23, 2019 /PRNewswire/ -- Gencurix, Inc., a molecular diagnostics company, ...

2019-08-23 08:00 1709

Gencurix Announces the First Comparison Data between GenesWell BCT and Oncotype DX

SEOUL, South Korea, Aug. 14, 2019 /PRNewswire/ -- Gencurix, Inc., a company dedicated in developmen...

2019-08-14 09:00 1803

New Publication Shows Different Result of Risk Classification between GenesWell BCT and Oncotype DX in Breast Cancer Patients 50 Years Old or Younger.

SEOUL, South Korea, Aug. 12, 2019 /PRNewswire/ -- Gencurix, Inc., a company dedicated in developmen...

2019-08-12 21:00 1710